Trial · NCT07888283
SURPASS: Stereotactic Ultra-hypofractionated Radiotherapy for Post-prostatectomy Patients: Adaptive Salvage SBRT
NCT07888283, Not applicable, Not yet recruiting, NYU Langone Health
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. SURPASS: Stereotactic Ultra-hypofractionated Radiotherapy for Post-prostatectomy Patients: Adaptive Salvage SBRT. Trials, record NCT07888283. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888283
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- SURPASS: Stereotactic Ultra-hypofractionated Radiotherapy for Post-prostatectomy Patients: Adaptive Salvage SBRT
- NCT number
- NCT07888283
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 30 participants, estimated
- Lead sponsor
- NYU Langone Health
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Adaptive stereotactic body radiotherapy (SBRT)
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Treatment completion rate | Day 15 | |
| Primary | Incidence of grade ≥3 treatment-related GU/GI toxicity | Month 1 | As per Common Terminology Criteria for Adverse Events (CTCAE) version 6.0 respectively. |
| Secondary | Time till onset of physician reported acute and late grade ≥2 and grade ≥3 GU/GI toxicity rates (CTCAE) | From Day 0 (start of treatment) until Day 15 (end of treatment) | |
| Secondary | Change in Expanded Prostate Cancer Index Composite-26 (EPIC-26) | Baseline, Month 24 | The EPIC-26 is a 26-item patient-reported outcome questionnaire developed to evaluate health-related quality of life and side-effect burden in men treated for localized prostate cancer. Scores range from 0-100. Higher scores indicate better functioning and lower symptom bother (fewer side effects), while lower scores reflect severe functional impairment or high symptom burden. |
| Secondary | Change in International Prostate Symptom Score (IPSS) | Baseline, Month 24 | The International Prostate Symptom Score (I-PSS) total score ranges from 0 to 35.0 to 7: Mild symptoms, 8 to 19: Moderate symptoms, 20 to 35: Severe symptoms |
| Secondary | Biochemical recurrence free survival | Month 12 | |
| Secondary | Biochemical recurrence free survival | Month 24 | |
| Secondary | Distant metastasis free survival | Month 12 | |
| Secondary | Distant metastasis free survival | Month 24 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888283
GET https://conductscience.org/api/trials/v1/NCT07888283/registered